G-CSF reduces incidence of chemotherapy-associated infections.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000517:prevention & control*; D010919:Placebos
D000970:Antineoplastic Agents; D010919:Placebos; D016179:Granulocyte Colony-Stimulating Factor